technolog media telecommun verizon hunt video woe continu
consum golden arch add account tri-stat domin
global pharmaceut highlight autoimmune/immunolog kol seri part emerg treatment landscap
moder sever asthma
page analyst certif import disclosur
automot retail august light vehicl sale review extra weekend labor day time incent boost sale
continu track consensu
increment progress gene therapi reimburs front
media internet commun daili daili provid posit guidanc invest
 ga
publish septemb
messag /strong report result even wors soft expect due rapid deceler lacroix
brand yet find bottom revis estim reflect even lower sale lacroix view lacroix stabil
least next year given increas competit lack meaning disrupt innov impair brand imag lower
ep estim reduc price target due lower
 footbal back pt
publish septemb
messag /strong close report strong result comp rose cc vs estim ep came
estim solid gross margin believ result demonstr continu momentum busi global continu
drive outsiz result across portfolio encourag continu momentum top quit challeng yoy comparison
year cc comp qoq given belief drive continu top-lin strength brand pursu signific global opportun
remain buy-rat rais pt higher top-line/earn forecast
page analyst certif import disclosur
 neutral invest spend cost weigh nation
media outlook lower pt
publish septemb
align justifi strong messag /strong report result morn issu initi outlook manag guid
adjust ebitda rang includ strateg invest model well estim
head earn forecast adj ebitda revis overwhelmingli driven manag see
posit synergi though larg off-set print declin invest lower-margin consum revenu
standard inflationari expens pt base lower ebitda guidanc /p /td /tr /tabl
publish septemb
messag /strong finish strong note retrospect walk away buy rate earli downgrad share
late may due concern valuat slow industri volum growth volum slow us insur volum msd vs
dd off-set strong price mix fee increas keep dd sale growth algo intact look ahead expect top-lin momentum
continu high valuat turn average potenti margin pressur hurrican dorian like limit upsid nt
continu favor exposur strong salvag auction fundament due attract valuat self-help /p /td /tr /tabl
keep faith despit bishop departur
publish septemb
messag /strong expect report earn septemb revis model incorpor tweak
assumpt reiter posit thesi ahead print continu think year strong organ sale growth acceler
ep ahead manag guidanc consensu decreas ep estim
maintain price target roll forward discount period /p /td /tr /tabl
page analyst certif import disclosur
publish septemb
style background-color ffffff ssage /font /strong font style background-color ffffff outlook bit noisi lighter anticip
cloud commentari stronger expect think share trend higher deadlin revenu outlook /font
came well expect style background-color ffffff howev higher cloud subscript mix outlook account
licens revenu shortfal encourag cloud ramp trend quot fulli ramp quot grew vs cohort
cloud deal project compound-annual-growth-rate margin guidanc previou guid surpris see lower mix
servic manag comment target likelihood refresh low /font /p /td /tr /tabl
neutral ebitda
publish septemb
align justifi strong messag /strong solid august sale beat driven us hardlin categori bolster case
bottom-lin out-performance specif sale top estim million gross margin like benefit healthi ga
result addit expans confid forecast ebitda growth
expect said share alreadi sport one highest valuat large-cap retail ebitda see exhibit level
buttress well-public open shanghai club remain neutral-r /p /td /tr /tabl
 soliri composit matter patent deni eu
ip situat also uncertain
publish septemb
messag /strong today receiv written feedback epo deni grant two comp matter patent soliri ab
would provid ip protect one two eu ip situat weigh stock appeal
revoc anoth soliri eu formul patent could take resolv evalu option appeal refus grant
thu expect eu ip overhang remain stock addit recent ipr challeng creat ip uncertainti
believ ip situat europ like keep share range-bound least anoth year /p /td /tr /tabl
page analyst certif import disclosur
 keep foot ball
publish septemb
messag /strong attend sell-sid meet member manag includ ceo read fah cfo patrick moor
vice-president ir david mann overal remain impress strong consist top-lin perform gener consecut
quarter posit comp favor secular tailwind signific white space opportun highli capabl manag team
view believ long-term outlook compani remain quit posit reiter buy rate remain confid
abil continu gain share optic retail market vision monday /p /td /tr /tabl
 new cfo network
publish septemb
align justifi strong messag /strong host ceo cfo vice-president ir investor meet new york today thrust
messag growth broker ancillari benefit product fast transform compani
benefit administr platform benefit network believ second half suffici de-risk guidanc
perspect enrol season come mostli contribut live ad
year-end voluntari benefit product benefit place creat new commiss revenu reaffirm buy rate
pt share /p /td /tr /tabl
 nejm editori take cautiou tone mdd
publish septemb
messag /strong full data phase ii trial oral gaba-a posit alloster modul major depress disord mdd
recent publish nejm target blank along
correspond editori one view potenti target blank
editori acknowledg need novel faster-act therapi new pharmacolog target
highlight caveat role mdd current address multipl on-going trial plan discuss trial
detail tomorrow kol call et dial pleas contact us confer call password /p /td /tr
page analyst certif import disclosur
ed ceconi rate case settlement start emerg
publish septemb
messag /strong morn ny public servic commiss issu memo settlement agreement in-principl parti
ceconi rate case settlement process still confidenti import mileston ceconi reiter view rate case
process yield neutral outcom chang roe cap structur capital-expenditure /p /td /tr /tabl
publish septemb
messag /strong spoke follow news fda grant prioriti review nda oral hb modifi
sickl cell pdufa date note accept file ahead buy-sid expect importantli
fda indic write href http //ir gbt com/news-releases/news-release-details/gbt-announces-us-food-and-drug-administration-
acceptance-new quot current plan hold quot /a adcom posit surpris lift near-term overhang
note investor draw parallel amrn got stuck adcom despit prioriti review howev case fda
ethyl indic /a quot plan hold adcom upon nda accept differ telegraph agenc view expect fda
approv
verizon hunt video woe continu
publish septemb
messag /strong back school season full swing ahead new iphon target blank href http //www techradar com/news/iphone-
xi releas /a provid updat thought quot four quot releas verizon model updat
new report structur summar follow key topic industri thought progress competit landscap
strategi new price plan releas new iphon mean wireless oper pressur amp
page analyst certif import disclosur
golden arch add account tri-stat domin
publish septemb
messag /strong target blank href http //www prnewswir com/news-releases/mcdonalds-adds-grubhub-
approxim
new york brand seamless second measur estim nyc market share
end
june nation share target blank href http //guggenheimsecur bluematrix com/sellside/emaildocview
note nyc domin /a opinion partnership valid domin market share import market like
nyc also skew independ make compel strateg partner well under-valued asset among parti deliveri aggreg
opinion likewis long-term potenti exist broaden partnership new region platform includ levelup mobil
carryout tapingo colleg campus /p /td /tr /tabl
nyc tri-stat area mcdeliveri avail
marketplac
expand mcdeliveri
highlight autoimmune/immunolog kol seri part emerg treatment landscap moder sever
publish septemb
align justifi strong messag /strong key takeaway discuss two asthma/allergi kol
strong san-par/regn /strong rapid growth continu least next sever year efficaci conveni drive
continu market share gain reimburs hurdl diminish alongsid broader label despit littl efficaci
differenti among antibodi fasenra like remain drug second choic dupix due
conveni treatment everi week anticip approv home auto-injector
strong fevipipr could gain traction oral treatment option poorli control patient kol skeptic drug match
efficaci current biolog among new biolog mechan develop kol optimist anti-
tslp strong azn/amgn novn-swx /strong vs take quot wait see quot view
anti-siglec atop diseas includ asthma /p /td /tr /tabl
publish septemb
messag /strong edit quot buzz quot random muse commun industri look
wireless offer announc t-mobil altic usa wake price cut earli august investor bit
cautiou develop among carrier handset promot key competit tool announc
like undermin view wireless competit benign /p /td /tr /tabl
august vehicl sale review extra weekend labor day time incent boost sale saar continu track
page analyst certif import disclosur
publish septemb
messag /strong august us light vehicl sale came mn ahead bbg consensu mn y/i highlight new
car incent spend continu increas spend per vehicl rise y/i repres third straight month higher incent light truck
continu take share bp y/i light truck sale increas y/i sell day adjust passeng car sale declin y/i sell
day adjust estim retail sale increas y/i august sell day adjust fleet sale declin lsd sell day adjust atp
continu expand healthi pace y/i larg consist ytd averag inventori level unit contract sequenti driven
slightli stronger expect daili sell rate august current mn full-year forecast appear conserv
track closer mn ytd august sale boost time labor day weekend august five weekend vs last year
four adjust season factor sell day adjust unit volum /p /td /tr /tabl
increment progress gene therapi reimburs front
publish septemb
promise-of-modern-medicin announc /a embarc program employers/insur regard gene therapi target blank href http //
report develop
respect program see posit first step think good sign insur work provid access gene therapi
notabl plan provid co-pay increment good news view overal plan reduc employ risk
risk-manag approach stop-loss reinsur note concern self-insur plan live us highlight
daili provid posit guidanc invest sustain lt growth fuller examin zg
publish septemb
analyst day includ posit margin three-year revenue/bil trend /li li style text-align justifi strong /strong
 wong recap annual inbound confer focus higher portfolio spend addit product reduc on-board friction amp
invest /li li style text-align justifi strong zg /strong /u fuller see inventori ramp requir signific capit lead
home end cash reserv /li /ul style text-align justifi strong news /strong fb
page analyst certif import disclosur
publish septemb
style background-color ffffff guggenheim host client util event includ annual tx power
ga wire bu tour /font font style background-color ffffff eei /font font style background-color ffffff meetings/util dinner
font font style background-color ffffff ndr /font font style background-color ffffff schedul among event scroll /font /font
style text-align justifi strong ceo brandt appear discuss shutoff /p style text-
align justifi strong amp revis outlook posit stabl /p strong ercot
strong iso set septemb demand record request conserv thurs/fri /p strong nc/d/duk dominion buy
solar project nc /p strong mvp file complianc monitor report weekli statu intervenor motion action
stormwat discharg /p strong nextera initi convert equiti offer /p style text-align justifi strong
atlanta ga light file respons data request /p style text-align justifi strong
north conserv district approv intervenor rate case /p style text-align justifi strong ferc
chair chatterje indic commiss may look modifi purpa /p /td /tr /tabl
page analyst certif import disclosur
inc
primari analyst jake fuller
page analyst certif import disclosur
primari analyst glen santangelo
page analyst certif import disclosur
explor product
page analyst certif import disclosur
